Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways

Human Molecular Genetics

Volumn 18, Issue 20, 2009, Pages 3955-3968

  Sancho, Rosa M ^a   Law, Bernard M H ^a   Harvey, Kirsten ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISHEVELLED 1; DISHEVELLED 2; DISHEVELLED 3; DISHEVELLED PROTEIN; GUANOSINE TRIPHOSPHATASE; HYBRID PROTEIN; LEUCINE RICH REPEAT KINASE 2; PROTEIN KINASE; ROC COR FUSION PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CELL AGGREGATION; CELL ORGANELLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; GROWTH CONE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NERVE CELL CULTURE; NEURITE; NEUROBLASTOMA CELL; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SH SY5Y CELL; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE; HUMANS; MUTATION; PARKINSON DISEASE; PHOSPHOPROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; WNT PROTEINS;

MAMMALIA;

EID: 70349576902     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp337     Document Type: Article

References (49)

1. Paisán-Ruíz, C., Jain, S., Evans, E.W., Gilks, W.P., Simón, J., van der Brug, M., López de Munain, A., Aparicio, S., Gil, A.M., Khan, N. et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron, 44, 595-600.
2. Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R.J., Calne, D.B. et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron, 44, 601-607.
3. Healy, D.G., Falchi, M., O'Sullivan, S.S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C.P., Goldwurm, S. et al. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: A case-control study. Lancet Neurol., 7, 583-590.
4. Paisán-Ruíz, C., Nath, P., Washecka, N., Gibbs, J.R. and Singleton, A.B. (2008) Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls. Hum. Mutat., 29, 485-490.
5. Khan, N.L., Jain, S., Lynch, J.M., Pavese, N., Abou-Sleiman, P., Holton, J.L., Healy, D.G., Gilks, W.P., Sweeney, M.G., Ganguly, M. et al. (2005) Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: Clinical, pathological, olfactory and functional imaging and genetic data. Brain, 128, 2786-2796.
6. Bosgraaf, L. and Van Haastert, P.J. (2003) Roc, a Ras/GTPase domain in complex proteins. Biochim. Biophys. Acta, 1643, 5-10.
7. Smith, W.W., Pei, Z., Jiang, H., Dawson, V.L., Dawson, T.M. and Ross, C.A. (2006) Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat. Neurosci., 9, 1231-1233.
8. Mata, I.F., Wedemeyer, W.J., Farrer, M.J., Taylor, J.P. and Gallo, K.A. (2006) LRRK2 in Parkinson's disease: Protein domains and functional insights. Trends Neurosci., 29, 286-293.
9. Guo, L., Gandhi, P.N., Wang, W., Petersen, R.B., Wilson-Delfosse, A.L. and Chen, S.G. (2007) The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Exp. Cell Res., 313, 3658-3670.
10. Gotthardt, K., Weyand, M., Kortholt, A., Van Haastert, P.J. and Wittinghofer, A. (2008) Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase. EMBO J., 27, 2239-2249.
11. Ito, G., Okai, T., Fujino, G., Takeda, K., Ichijo, H., Katada, T. and Iwatsubo, T. (2007) GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease. Biochemistry, 46, 1380-1388.
12. West, A.B., Moore, D.J., Choi, C., Andrabi, S.A., Li, X., Dikeman, D., Biskup, S., Zhang, Z., Lim, K.L., Dawson, V.L. and Dawson, T.M. (2007) Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum. Mol. Genet., 16, 223-232.
13. Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, A., van der Brug, M.P., Beilina, A., Blackinton, J., Thomas, K.J. et al. (2006) Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol. Dis., 23, 329-341.
14. Lewis, P.A., Greggio, E., Beilina, A., Jain, S., Baker, A. and Cookson, M.R. (2007) The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem. Biophys. Res. Commun., 357, 668-671.
15. Li, X., Tan, Y.C., Poulose, S., Olanow, C.W., Huang, X.Y. and Yue, Z. (2007) Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants. J. Neurochem., 103, 238-247.
16. Jaleel, M., Nichols, R.J., Deak, M., Campbell, D.G., Gillardon, F., Knebel, A. and Alessi, D.R. (2007) LRRK2 phosphorylates moesin at threonine-558: Characterization of how Parkinson's disease mutants affect kinase activity. Biochem. J., 405, 307-317.
17. Greggio, E., Zambrano, I., Kaganovich, A., Beilina, A., Taymans, J.M., Daniëls, V., Lewis, P., Jain, S., Ding, J., Syed, A. et al. (2008) The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation. J. Biol. Chem., 13, 16906-16914.
18. Bos, J.L., Rehmann, H. and Wittinghofer, A. (2007) GEFs and GAPs: critical elements in the control of small G proteins. Cell, 129 865-877.
19. Wallingford, J.B. and Habas, R. (2005) The developmental biology of Dishevelled: An enigmatic protein governing cell fate and cell polarity. Development, 132, 4421-4436.
20. Habas, R., Dawid, I.B. and He, X. (2003) Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. Genes Dev., 17, 295-309.
21. Ahmad-Annuar, A., Ciani, L., Simeonidis, I., Herreros, J., Fredj, N.B., Rosso, S.B., Hall, A., Brickley, S. and Salinas, P.C. (2006) Signaling across the synapse: A role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release. J. Cell Biol., 174, 127-139.
22. Ciani, L. and Salinas, P.C. (2007) c-Jun N-terminal kinase (JNK) cooperates with Gsk3beta to regulate dishevelled-mediated microtubule stability. BMC Cell. Biol., 8, 27.
23. Zhang, X., Zhu, J., Yang, G.Y., Wang, Q.J., Qian, L., Chen, Y.M., Chen, F., Tao, Y., Hu, H.S., Wang, T. and Luo, Z.G. (2007) Dishevelled promotes axon differentiation by regulating atypical protein kinase C. Nat. Cell Biol., 9, 743-754.
24. Schulte, G., Bryja, V., Rawal, N., Castelo-Branco, G., Sousa, K.M. and Arenas, E. (2005) Purified Wnt-5a increases differentiation of midbrain dopaminergic cells and dishevelled phosphorylation. J. Neurochem., 92, 1550-1553.
25. Castelo-Branco, G., Sousa, K.M., Bryja, V., Pinto, L., Wagner, J. and Arenas, E. (2006) Ventral midbrain glia express region-specific transcription factors and regulate dopaminergic neurogenesis through Wnt-5a secretion. Mol. Cell. Neurosci., 31, 251-262.
26. Bryja, V., Schulte, G., Rawal, N., Grahn, A. and Arenas, E. (2007) Wnt-5a induces Dishevelled phosphorylation and dopaminergic differentiation via a CK1-dependent mechanism. J. Cell Sci., 120, 586-595.
27. Andersson, E.R., Prakash, N., Cajanek, L., Minina, E., Bryja, V., Bryjova, L., Yamaguchi, T.P., Hall, A.C., Wurst, W. and Arenas, E. (2008) Wnt5a regulates ventral midbrain morphogenesis and the development of A9-A10 dopaminergic cells in vivo. PLoS ONE, 3 e3517.
28. MacLeod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K. and Abeliovich, A. (2006) The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron, 52, 587-593.
29. Plowey, E.D., Cherra, S.J. III, Liu, Y.J. and Chu, C.T. (2008) Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J. Neurochem., 105, 1048-1056.
30. Sämann, J., Hegermann, J., Gromoff, E.V., Eimer, S., Baumeister, R. and Schmidt, E. (2009) Caenorhabditis elegans LRK-1 and PINK-1 act antagonistically in stress response and neurite outgrowth. J. Biol. Chem., 284, 16482-16491.
31. Lesnick, T.G., Papapetropoulos, S., Mash, D.C., Ffrench-Mullen, J., Shehadeh, L., de Andrade, M., Henley, J.R., Rocca, W.A., Ahlskog, J.E. and Maraganore, D.M. (2007) A genomic pathway approach to a complex disease: Axon guidance and Parkinson disease. PLoS Genet., 3 e98.
32. LeBoeuf, A.C., Levy, S.F., Gaylord, M., Bhattacharya, A., Singh, A.K., Jordan, M.A., Wilson, L. and Feinstein, S.C. (2008) FTDP-17 mutations in Tau alter the regulation of microtubule dynamics: An 'alternative core' model for normal and pathological Tau action. J. Biol. Chem., 283, 36406-36415.
33. Feinstein, S.C. and Wilson, L. (2005) Inability of tau to properly regulate neuronal microtubule dynamics: A loss-of-function mechanism by which tau might mediate neuronal cell death. Biochim. Biophys. Acta. 1739, 268-279.
34. Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H. and Del Tredici, K. (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res., 318, 121-134.
35. Habas, R., Kato, Y. and He, X. (2001) Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1. Cell, 107, 843-854.
36. Ko, H.S., Bailey, R., Smith, W.W., Liu, Z., Shin, J.H., Lee, Y.I., Zhang, Y.J., Jiang, H., Ross, C.A., Moore, D.J. et al. (2009) CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity. Proc. Natl Acad. Sci. USA, 106, 2897-2902.
37. Ding, X. and Goldberg, M.S. (2009) Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP. PLoS One, 4, e5949.
38. Schwarz-Romond, T., Fiedler, M., Shibata, N., Butler, P.J., Kikuchi, A., Higuchi, Y. and Bienz, M. (2007) The DIX domain of Dishevelled confers Wnt signaling by dynamic polymerization. Nat. Struct. Mol. Biol., 14, 484-492.
39. De Ferrari, G.V., Chacón, M.A., Barría, M.I., Garrido, J.L., Godoy, J.A., Olivares, G., Reyes, A.E., Alvarez, A., Bronfman, M. and Inestrosa, N.C. (2003) Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol. Psychiatry, 8, 195-208.
40. Russ, C., Lovestone, S. and Powell, J.F. (2002) Identification of genomic organisation, sequence variants and analysis of the role of the human dishevelled 1 gene in late onset Alzheimer's disease. Mol. Psychiatry, 7, 104-109.
41. Toledo, E.M., Colombres, M. and Inestrosa, N.C. (2008) Wnt signalling in neuroprotection and stem cell differentiation. Prog. Neurobiol., 86, 281-296.
42. Häbig, K., Walter, M., Poths, S., Riess, O. and Bonin, M. (2008) RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player. Neurogenetics, 9, 83-94.
43. Long, J.M., LaPorte, P., Paylor, R. and Wynshaw-Boris, A. (2004) Expanded characterization of the social interaction abnormalities in mice lacking Dvl1. Genes Brain Behav., 3, 51-62.
44. Hamblet, N.S., Lijam, N., Ruiz-Lozano, P., Wang, J., Yang, Y., Luo, Z., Mei, L., Chien, K.R., Sussman, D.J. and Wynshaw-Boris, A. (2002) Dishevelled 2 is essential for cardiac outflow tract development, somite segmentation and neural tube closure. Development, 129, 5827-5838.
45. Etheridge, S.L., Ray, S., Li, S., Hamblet, N.S., Lijam, N., Tsang, M., Greer, J., Kardos, N., Wang, J., Sussman, D.J., Chen, P. and Wynshaw-Boris, A. (2008) Murine dishevelled 3 functions in redundant pathways with dishevelled 1 and 2 in normal cardiac outflow tract, cochlea, and neural tube development. PLoS Genet., 4, e1000259.
46. Dorus, S., Vallender, E.J., Evans, P.D., Anderson, J.R., Gilbert, S.L., Mahowald, M., Wyckoff, G.J., Malcom, C.M. and Lahn, B.T. (2004) Accelerated evolution of nervous system genes in the origin of Homo sapiens. Cell, 119, 1027-1040.
47. Fuller, K.J., Morse, M.A., White, J.H., Dowell, S.J. and Sims, M.J. (1998) Development of a yeast trihybrid screen using stable yeast strains and regulated protein expression. Biotechniques, 25, 85-92.
48. Ramamoorthy, K., Wang, F., Chen, I.C., Norris, J.D., McDonnell, D.P., Leonard, L.S., Gaido, K.W., Bocchinfuso, W.P., Korach, K.S. and Safe, S. (1997) Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: No apparent synergism. Endocrinology, 138, 1520-1527.
49. Harvey, K., Duguid, I.C., Alldred, M.J., Beatty, S.E., Ward, H., Keep, N.H., Lingenfelter, S.E., Pearce, B.R., Lundgren, J., Owen, M.J. et al. (2004) The GDP-GTP exchange factor collybistin: An essential determinant of neuronal gephyrin clustering. J. Neurosci., 24 5816-5826.